Premarin and Renagel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Premarin (estrogens, conjugated) and Renagel (sevelamer hydrochloride). Common drug interactions include pain among females.

The phase IV clinical study analyzes what interactions people have when they take Premarin and Renagel. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Premarin?

Premarin has active ingredients of estrogens, conjugated. It is often used in hormone replacement therapy. eHealthMe is studying from 99,630 Premarin users. Check the latest studies of Premarin.

What is Renagel?

Renagel has active ingredients of sevelamer hydrochloride. eHealthMe is studying from 8,246 Renagel users. Check the latest studies of Renagel.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

57 people who take Premarin and Renagel together, and have interactions are studied.

Premarin and Renagel drug interactions.

What are the common drug interactions of Premarin and Renagel, by gender? *:

female:

  1. Pain
  2. Oedema peripheral (superficial swelling)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Muscular weakness (muscle weakness)
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  7. Mobility decreased (ability to move is reduced)
  8. Adrenal neoplasm (abnormal growth of adrenal gland)
  9. Ankle fracture
  10. Arthralgia (joint pain)

male:

n/a

What are the common drug interactions of Premarin and Renagel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiac arrest
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Renal failure chronic (long lasting kidney dysfunction)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Unresponsive to stimuli
  6. Bacteraemia (presence of bacteria in the blood)
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Haemorrhage (bleeding)
  9. Staphylococcal bacteraemia (a bacterial infection of blood)

50-59:

  1. Anxiety
  2. Deformity (disfigurement)
  3. Infection
  4. Injury
  5. Tooth extraction
  6. Disability
  7. Neuropathy peripheral (surface nerve damage)
  8. Bone neoplasm (tumour of bone)
  9. Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)
  10. Skin erosion (a discontinuity of the skin)

60+:

  1. Pain
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Pneumonia
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Sinusitis (inflammation of sinus)
  10. Tinnitus (a ringing in the ears)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 13 people, 22.81%
  2. Light Chain Analysis Increased: 12 people, 21.05%
  3. Neoplasm Malignant (cancer tumour): 9 people, 15.79%
  4. Hypertensive Heart Disease: 3 people, 5.26%
  5. Chronic Renal Failure (kidney failure): 3 people, 5.26%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Premarin and Renagel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Premarin and Renagel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Premarin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Renagel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Premarin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Renagel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on estrogens, conjugated and sevelamer hydrochloride (the active ingredients of Premarin and Renagel, respectively), and Premarin and Renagel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: